Alto Neuroscience (ANRO)
NYSE • ANRO • US02157Q1094
ORTEX Data Highlights
ORTEX Data Highlights
As of Oct 27, 2026, ORTEX estimated 17.5% of free float sold short, 7.8 days to cover, cost to borrow 0.51%. Sign up for live short interest data.
Market Cap
1.25b USD | # 4816 in US
Volume
591.87k shares | 16.82m USD
Shares Outstanding
39.24m
Free Float Shares
75.42% | 29.59m
